9¿ù 22ÀÏ
9¿ù 23ÀÏ-24ÀÏ
9¿ù 24ÀÏ-25ÀÏ
º¸½ºÅÏ¿¡¼ °³ÃֵǴ Discovery On Target 2025¿¡¼ ¸¸³³½Ã´Ù!
¿ÃÇØ·Î 23³â°¸¦ ¸ÂÀÌÇÏ´Â Discovery on Target(DOT)´Â "ÇÖ" ÀǾàǰ Ÿ°Ù°ú ÀÌ Å¸°ÙÀ» Ãß±¸ÇÏ´Â ½Å±Ô ¸ð´Þ¸®Æ¼, ±â¼ú, Àü·«¿¡ ÃÊÁ¡À» ¸ÂÃá ¼¼°è ÃÖ°íÀÇ À̺¥Æ®ÀÔ´Ï´Ù. ÀúºÐÀÚºÎÅÍ ¹ÙÀÌ¿À·ÎÁ÷½º±îÁö, Ű¸Þ¶ó ¹× ÄÁÁê°ÔÀÌÆ®±îÁö, ¼ö¸¹Àº ÄÁÆÛ·±½º, ½ÉÆ÷Áö¾ö, ¼îÆ®ÄÚ½º, Æ®·¹ÀÌ´× ¼¼¹Ì³ª°¡ ½Å±Ô Ä¡·áÀÇ ¹ß°ß¡¤°³¹ßÀ» ¼º°ø½Ã۱â À§ÇÑ ÁÖ¿ä ÀλçÀÌÆ®¸¦ Á¦°øÇÕ´Ï´Ù. 4Àϰ£ ÁøÇàµÇ´Â À̺¥Æ®¿¡¼´Â ¾ÏÄ¡·á, ´Ü¹éÁú ºÐÇØ, À¯µµ Á¢±Ù, AI/ML, ¸·´Ü¹éÁú, Æ®·£½º·¹À̼ųΠ¸ðµ¨, ÇÕ¼º»ý¹°ÇÐ, ±âŸ °ü·Ã ÅäÇÈ µî Ÿ°Ù ½Äº°°ú ¸®µå Á¦³Ê·¹À̼ÇÀÇ Çõ½ÅÀ» ´Ù·ì´Ï´Ù. ¿ÃÇØ´Â »õ·Ó°Ô GLP-1, MASH¡¤ºñ¸¸, ADC¡¤ÀÌÁ߯¯À̼º, DNA Ç¥Àû ÀúºÐÀÚ µîµµ Ãß°¡µÇ¾ú½À´Ï´Ù.
ÀÌ À̺¥Æ®¿¡¼´Â Àü ¼¼°è 1,100¸í ÀÌ»ó Drug Discovery Àü¹®°¡¿Í ÀÇ¹Ì ÀÖ´Â ´ëȸ¦ ³ª´©°í, ³×Æ®¿öÅ·À» Çü¼ºÇÒ ¼ö Àִ Ưº°ÇÑ ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù. 220°³ ÀÌ»óÀÇ ÇÁ·¹Á¨Å×À̼Ç, 100°³ ÀÌ»óÀÇ Æ÷½ºÅÍ, ÆÐ³Î µð½ºÄ¿¼Ç ¹× ºê·¹ÀÌÅ©¾Æ¿ô µð½ºÄ¿¼Ç µîÀÇ µ¿½Ã °³ÃÖ ¼¼¼Ç°ú ÇÔ²² 1´ë1 ³×Æ®¿öÅ· À̺¥Æ®¿¡¼´Â ¿Â»çÀÌÆ® °æÇèÀ» Ä¿½ºÅ͸¶ÀÌÁîÇϰí, ÇâÈÄ °øµ¿ ¿¬±¸ÀÚ°¡ µÉ °¡´É¼ºÀÌ ÀÖ´Â ¹®Á¦ ÇØ°áÀÚ ¹× ¼Ö·ç¼Ç ÇÁ·Î¹ÙÀÌ´õ¿Í ±³·ùÇÒ ¼ö ÀÖ½À´Ï´Ù. °è¼Ó ¼ºÀåÇÏ´Â DOT Ä¿¹Â´ÏƼ¿¡ Âü°¡ÇÏ¿© Drug Discovery¿¡¼ »õ·Î¿î ¾ÆÀ̵ð¾î ¹× µ¿ÇâÀ» ¼±µµÇØ º¸¼¼¿ä. º¸½ºÅÏ¿¡¼ ¿©·¯ºÐÀ» ¸¸³ª ºË±â¸¦ ±â´ëÇÕ´Ï´Ù!
¼öÄ¡·Î º¸´Â Discovery on Target 2024
1,100+
Attendees
220+
Presentations
110+
Research Posters
13
Conference Tracks
5
Symposia
2
In-Person Training Seminars
12
In-Person Short Courses
90
Exhibitors
22
Countries Represented
As of 5/8/25
2025³â Ç÷¹³Ê¸® ¼¼¼Ç(±âÁ¶ °¿¬ ÇÁ·Î±×·¥)
WEDNESDAY,
SEPTEMBER 24:
The Radicalization of
Drug Discovery
Gregory L. Verdine, PhD
President & CEO, LifeMine Therapeutics
WEDNESDAY,
SEPTEMBER 24TH:
GLP-1 Unveiled: Key Takeaways for Next-Generation Drug Discovery
Lotte Bjerre Knudsen, PhD
Chief Scientific Advisor, Head of IDEA (Innovation & Data Experimentation Advancement), Novo Nordisk AS
THURSDAY,
SEPTEMBER 25:
Venture Capitalist Insights into Trends in Drug Discovery
PANEL MODERATOR:
Daniel A. Erlanson, PhD
Chief Innovation Officer, Frontier Medicines Corporation
THURSDAY, SEPTEMBER 25: COLLABORATIVE CONVERSATION
Connecting the DOTs to Spark Change!
MODERATORS:
Saudat Fadeyi, PhD, MBA
Head, Business Development & Strategy,Samyang Biopharm USA, Inc.
Sean Ekins, PhD
Founder & CEO, Collaborations Pharmaceuticals
Shruthi Bharadwaj, PhD
Program Leader, MIT
Raquel Mura, DPharm
Founder, RGM Life Sciences Consulting; former VP & Head R&D, Sanofi
Nisha Perez, PhD
VP Preclinical Development & Clinical Pharmacology,ROME Therapeutics